• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:张立,曲宏亮,孙启泉,苑菲菲,薛云丽.超高效液相色谱-串联质谱法定量分析羟考酮纳洛酮缓释片中基因毒性杂质7,8-二脱氢纳洛酮[J].药学研究,2025,44(1):32-35[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2804次   下载 1987次 本文二维码信息
码上扫一扫!
超高效液相色谱-串联质谱法定量分析羟考酮纳洛酮缓释片中基因毒性杂质7,8-二脱氢纳洛酮
张立,曲宏亮,孙启泉,苑菲菲,薛云丽
字体:加大+|默认|缩小-
(山东绿叶制药有限公司,山东 烟台 264003)
摘要:
目的 建立羟考酮纳洛酮缓释片中潜在基因毒性杂质7,8-二脱氢纳洛酮的超高效液相色谱-串联质谱(UHPLC-MS/MS)检测方法。方法 色谱柱为Waters Acquity CSH C18(2.1 mm×150 mm,1.7 μm),以0.77 g·L-1乙酸铵水溶液(冰醋酸调节pH为5.0)为流动相A,以乙腈为流动相B,梯度洗脱,流速为0.5 mL·min-1,柱温为50 ℃。采用多反应监测(MRM)模式,对羟考酮纳洛酮缓释片中的7,8-二脱氢纳洛酮进行定量检测。结果 7,8-二脱氢纳洛酮浓度在1.2~48 ng·mL-1范围内具有良好的线性关系。检测限和定量限分别为0.6 ng·mL-1和1.2 ng·mL-1。低、中、高3个浓度的加样回收率在93%~99%之间(n=9),RSD为2.4%。结论 该方法灵敏度高、专属性强,可用于羟考酮纳洛酮缓释片中7,8-二脱氢纳洛酮杂质的含量测定,为羟考酮纳洛酮缓释片杂质控制提供科学依据和定量分析方法。
关键词:  羟考酮纳洛酮缓释片  潜在基因毒性杂质  7,8二脱氢纳洛酮  超高效液相色谱-串联质谱  定量分析
DOI:10.13506/j.cnki.jpr.2025.01.006
基金项目:泰山产业领军人才工程资助项目;烟台市省级以上领军人才专项配套经费资助项目
出版日期:2025-01-25
Quantitative analysis of genotoxic impurity 7, 8-didehydronaloxone in Oxycodone and Naloxone Hydrochloride Sustained-release Tablets by UHPLC-MS/MS
ZHANG Li,QU Hongliang,SUN Qiquan,YUAN Feifei,XUE Yunli
(Shandong Luye Pharmaceutical Co., Ltd.,Yantai 264003, China)
Abstract:
Objective To establish an UHPLC-MS/MS method for determination of potential genotoxic impurity 7,8-didehydronaloxone in oxycodone and naloxone sustained-release tablets.Methods The separation was performed on Waters Acquity CSH C18 (2.1 mm×150 mm, 1.7 μm) column with the mobile phase consisting of 0.77 g·L-1 ammonium acetate aqueous solution (mobile phase A) and acetonitrile (mobile phase B) under a gradient elution at a flow rate of 0.5 mL·min-1 and a column temperature of 50 ℃. Multiple reaction monitoring (MRM) mode was used to quantitative detection of 7,8-didehydronaloxone in oxycodone and naloxone sustained-release tablets.Results The calibration curves was in good linearity for 7,8-didehydronaloxone in the range of 1.2-48 ng·mL-1. The LOD and LOQ were 0.6ng·mL-1 and 1.2ng·mL-1, respectively. The recoveries at low, middle, and high spiked concentrations was 93%-99% (n=9), and the RSD was 2.4%. Conclusion The method was sensitive and accurate, which can be applied for the quantifications of 7,8-didehydronaloxone in oxycodone and naloxone sustained-release tablets, providing scientific basis and quantitative analysis method for impurity control of oxycodone and naloxone sustained-release tablets.
Key words:  Oxycodone and naloxone sustained-release tablets  Potential genotoxic impurity  7,8-didehydronaloxone, UHPLC-MS/MS  Quantitative analysis method
今日访问量:2488    总访问量:55338929
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司